ENFOQUE REGULATORIO Y ANÁLISIS DE LA EVALUACIÓN DE ESTUDIOS DE FARMACOLOGÍA CLÍNICA POR PARTE DE LA ADMINISTRACIÓN NACIONAL DE MEDICAMENTOS, ALIMENTOS Y TECNOLOGÍA MÉDICA, DURANTE EL PERÍODO DE LA PANDEMIA DE COVID-19

Traversi, Laura; Murias, María Alejandra; Gonzalez, María Laura; Papayannis, Cristina; Delgado, Claudia Carolina; Spelta, María Gabriela; Sammartino, Inés; Kataife, Fanny; Bisio, Nelida Agustina.
Revista Científica ANMAT ; 2(Año 5): 1-8, 2021. ilus, graf, tab
Artigo em Espanhol | BINACIS | ID: biblio-1349222

Documentos relacionados

  1. Host Recovery from Respiratory Viral Infection.
  2. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
  3. Human Antibodies for Viral Infections.
  4. The humoral response and antibodies against SARS-CoV-2 infection.
  5. Better, Faster, Cheaper: Recent Advances in Cryo-Electron Microscopy.
  6. Bringing research to the intensive care setting.
  7. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.
  8. Haunting innate immune memories of COVID-19.
  9. Recovering from the stress of the COVID-19 pandemic.
  10. IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19.